These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2495052)

  • 1. Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.
    Youle M; Clarbour J; Farthing C; Connolly M; Hawkins D; Staughton R; Gazzard B
    BMJ; 1989 Feb; 298(6671):432. PubMed ID: 2495052
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: case report and review.
    Ball SC; Sepkowitz KA; Jacobs JL
    Am J Gastroenterol; 1997 Jan; 92(1):169-70. PubMed ID: 8995965
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in oral aphthous ulceration in patients with HIV infection.
    Henriquet F; Roy MT; Repetto T; Fusco F
    Palliat Med; 1994; 8(3):255-6. PubMed ID: 7952375
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: successful treatment with thalidomide.
    Radeff B; Kuffer R; Samson J
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):523-5. PubMed ID: 2212162
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide: treatment of severe recurrent aphthous stomatitis in patients with AIDS.
    Nicolau DP; West TE
    DICP; 1990 Nov; 24(11):1054-6. PubMed ID: 2275226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide: treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus.
    Ghigliotti G; Repetto T; Farris A; Roy MT; De Marchi R
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):271-2. PubMed ID: 8432932
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thalidomide, the treatment of choice in aphthae in HIV infection].
    Samson J; Kuffer R; Radeff B
    Presse Med; 1990 Apr; 19(15):722. PubMed ID: 2139969
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus.
    Weidle PJ
    Am J Health Syst Pharm; 1996 Feb; 53(4):368, 371-2, 378. PubMed ID: 8673657
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.
    Paterson DL; Georghiou PR; Allworth AM; Kemp RJ
    Clin Infect Dis; 1995 Feb; 20(2):250-4. PubMed ID: 7742424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide effective for oral ulcers.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide use is associated with weight gain in HIV-1-positive clients.
    Sharp M; Getty J; Klausner JD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):392. PubMed ID: 9342262
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.
    Shetty K
    Spec Care Dentist; 2005; 25(5):236-41. PubMed ID: 16454100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide for severe aphthous ulceration in patients with human immunodeficiency virus (HIV) infection.
    Oldfield EC
    Am J Gastroenterol; 1994 Dec; 89(12):2276-7. PubMed ID: 7977265
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide pros and cons.
    Am J Nurs; 1998 Apr; 98(4):63. PubMed ID: 9556688
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide heals HIV-related oral ulcers, but caution is required.
    Am J Health Syst Pharm; 1997 Jul; 54(13):1485-6. PubMed ID: 9217937
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of thalidomide on orogenital ulceration.
    Bowers PW; Powell RJ
    Br Med J (Clin Res Ed); 1983 Sep; 287(6395):799-800. PubMed ID: 6412834
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide and wasting.
    Posit Aware; 1995; VI(6):5. PubMed ID: 11363147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.